Literature DB >> 19266915

Glycaemic trend during Ramadan in fasting diabetic subjects: a study from Pakistan.

M Y Ahmadani1, M Riaz, A Fawwad, M Z I Hydrie, R Hakeem, A Basit.   

Abstract

The aim of this questionnaire based survey was to assess the glycaemic control care and management of our fasting diabetic subjects. This retrospective study was carried out at Baqai Institute of Diabetology and Endocrinology, its affiliated centers and Memon Diabetic Centre of Karachi. Data was collected by a questionnaire including socio-demographic data, duration of diabetes, life style, diet and treatment during and preceding Ramadan of year 2004. All Known diabetic Muslim subjects except children below 10 years were included. The subjects were asked if they had observed any of the hypoglycemic or hyperglycemic symptoms. The major severity of the symptoms was assessed depending upon the assistance needed. The plasma glucose level during these episodes was recorded where it was available. During the month of Ramadan 327 out of 453 subjects (72.5%) fasted. Mean age of subjects was 50.3 +/- 12.6 years. Average duration of diabetes was 9.3 +/- 7.3 years. Majority of the subjects (96.3%) fasted with type 2 diabetes while only 3.7% fasted with type I diabetes. Subjects fasted for an average of 25 days. Overall prevalence of hypoglycemia and hyperglycemia was 21.7 and 19.8%, respectively. Only 4.0% had major hypoglycemic episodes, while 8% had major hyperglycemic episodes. The present study suggests that all diabetic subjects who intend to fast should be counseled before Ramadan about change in medication timings and dose, dietary changes and pattern of physical activity and about role of self-monitoring of blood glucose especially during acute symptoms.

Entities:  

Mesh:

Year:  2008        PMID: 19266915     DOI: 10.3923/pjbs.2008.2044.2047

Source DB:  PubMed          Journal:  Pak J Biol Sci        ISSN: 1028-8880


  9 in total

1.  Cultural influences on medicine use among first-generation Pakistani immigrants in Norway.

Authors:  Helle Håkonsen; Else-Lydia Toverud
Journal:  Eur J Clin Pharmacol       Date:  2011-08-12       Impact factor: 2.953

Review 2.  Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients.

Authors:  Kamran Ma Aziz
Journal:  Diabetes Metab Syndr Obes       Date:  2015-04-16       Impact factor: 3.168

3.  Fasting with diabetes: a prospective observational study.

Authors:  Muhammad Jawad Noon; Haseeb Ahmad Khawaja; Osama Ishtiaq; Quratulain Khawaja; Sana Minhas; Asfandyar Khan Niazi; Abdul Mannan Khan Minhas; Umar Rasool Malhi
Journal:  BMJ Glob Health       Date:  2016-09-08

Review 4.  Effects of Time-Restricted Feeding during Ramadan on Dietary Intake, Body Composition and Metabolic Outcomes.

Authors:  Farhana Osman; Sumanto Haldar; Christiani Jeyakumar Henry
Journal:  Nutrients       Date:  2020-08-17       Impact factor: 5.717

5.  Glycemic Control among Pregnant Diabetic Women on Insulin Who Fasted During Ramadan.

Authors:  Nor Azlin Mohamed Ismail; Hadijat Olaide Raji; Norashikin Abd Wahab; Norlaila Mustafa; Nor Azmi Kamaruddin; Muhammad Abdul Jamil
Journal:  Iran J Med Sci       Date:  2011-12

6.  Implementation of Ramadan-specific diabetes management recommendations: a multi-centered prospective study from Pakistan.

Authors:  Muhammad Yakoob Ahmedani; Syed Faraz Danish Alvi; Muhammad Saif Ul Haque; Asher Fawwad; Abdul Basit
Journal:  J Diabetes Metab Disord       Date:  2014-02-21

Review 7.  Options for Controlling Type 2 Diabetes during Ramadan.

Authors:  Mussa H Almalki; Fahad Alshahrani
Journal:  Front Endocrinol (Lausanne)       Date:  2016-04-18       Impact factor: 5.555

Review 8.  Filling the Knowledge Gap in Diabetes Management During Ramadan: the Evolving Role of Trial Evidence.

Authors:  Saud Al Sifri; Kashif Rizvi
Journal:  Diabetes Ther       Date:  2016-04-18       Impact factor: 2.945

9.  Impact of Ramadan focused education program on hypoglycemic risk and metabolic control for patients with type 2 diabetes.

Authors:  Ayla M Tourkmani; Mohamed Azmi Hassali; Turki J Alharbi; Hesham I Alkhashan; Aljoharah H Alobikan; Ahmed H Bakhiet; Hala B Alqahtani; Alian A Alrasheedy; Ahmed D Alawwad; Adel M Mishriky; Hisham Aljadhey
Journal:  Patient Prefer Adherence       Date:  2016-09-06       Impact factor: 2.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.